J. Lawrence Steinman's most recent trade in BioAtla Inc was a trade of 23,500 Common Stock done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAtla Inc | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 23,500 | 78,459 | - | 0 | Common Stock | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 110,000 | 110,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 110,000 | 110,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 48,198 | 115,732 | - | 0 | Common Stock | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 44,959 | 112,493 | - | 0 | Common Stock | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 67,534 | - | 0 | Common Stock | |
| BioAtla Inc | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 54,959 | - | 0 | Common Stock | |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| BioAtla Inc | J. Lawrence Steinman | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 19 Dec 2023 | 20,000 | 38,459 | - | 2.1 | 41,048 | Common Stock |
| BioAtla Inc | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Purchase of securities on an exchange or from another person at price $ 0.43 per share. | 02 Jun 2023 | 30,000 | 1,327,174 | - | 0.4 | 12,930 | Common Stock |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 01 Jun 2023 | 18,000 | 48,129 | - | 1.2 | 22,068 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 28 Nov 2022 | 5,000 | 1,287,174 | - | 1.0 | 4,900 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 22 Nov 2022 | 5,000 | 1,282,174 | - | 1.0 | 4,950 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 1.10 per share. | 26 Oct 2022 | 5,000 | 1,277,174 | - | 1.1 | 5,500 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 1.02 per share. | 27 Jun 2022 | 5,000 | 1,267,174 | - | 1.0 | 5,100 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 27 Jun 2022 | 5,000 | 1,272,174 | - | 1 | 5,000 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 27 Jun 2022 | 5,000 | 1,262,174 | - | 1 | 5,000 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 23 Jun 2022 | 5,000 | 1,257,174 | - | 1 | 5,000 | Common Stock |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 652,174 | 1,252,174 | - | 0 | Common Stock | |
| Pasithea Therapeutics Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 100,000 | 100,000 | - | - | Stock option (to acquire common stock) | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 08 Dec 2021 | 5,000 | 602,574 | - | 4.3 | 21,350 | Common Stock |
| BioAtla Inc | Lawrence J. Steinman | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 02 Nov 2021 | 450 | 18,459 | - | 30 | 13,500 | Common Stock |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 6.00 per share. | 30 Sep 2021 | 5,216 | 597,574 | - | 6 | 31,296 | Common Stock |
| BioAtla Inc | Lawrence J. Steinman | Director | Sale of securities on an exchange or to another person at price $ 36.82 per share. | 15 Sep 2021 | 450 | 18,909 | - | 36.8 | 16,569 | Common Stock |
| BioAtla Inc | Lawrence J. Steinman | Director | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 16 Aug 2021 | 450 | 19,359 | - | 40.6 | 18,270 | Common Stock |
| BioAtla Inc | Lawrence J. Steinman | Director | Sale of securities on an exchange or to another person at price $ 38.29 per share. | 15 Jul 2021 | 450 | 19,809 | - | 38.3 | 17,231 | Common Stock |
| BioAtla Inc | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 12,307 | 12,307 | - | - | Stock Option (right to buy) | |
| BioAtla Inc | Lawrence J. Steinman | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2021 | 5,388 | 20,259 | - | 0 | Common Stock | |
| 180 Life Sciences Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 6.14 per share. | 07 Apr 2021 | 22,585 | 592,358 | - | 6.1 | 138,672 | Common Stock |